2m 2m 2m 2m 2m 2m 2m
VAXCYTE (PCVX)
NASDAQ
$57.02-$0.010 (-0.02%)
Price as of Jul 13, 2026 6:18 PM EDT- $8.4BMarket Cap
- 56.76%1-Year Change
- BiotechnologyIndustry
VAXCYTE (PCVX)
$57.02-$0.010 (-0.02%)
PCVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.03 | ||
Change | -$1.18 (-2.03%) | ||
Open | $58.13 | ||
High | $58.24 | ||
Low | $56.59 | ||
Previous Close | $58.21 | ||
Volume | 831,104 | ||
30-Day Average Volume | 1,981,510 | ||
1-Week Change | 0.12% | ||
1-Month Change | 20.16% | ||
1-Year Change | 56.76% | ||
3-Year Change | 17.73% | ||
5-Year Change | 155.28% | ||
Fundamentals | |||
Shares Outstanding | 144.4M | ||
Total Assets | $3.3B | ||
Market Cap | $8.4B | ||
Enterprise Value | $8.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$320.6M | ||
Free Cash Flow | -$282.7M | ||
EBIT | -$320.6M | ||
EBITDA | -$317.7M | ||
Net Working Capital | $1.6B | ||
EPS | -$2.30 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -25 | ||
PEG | 1 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue